| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/22/1999 | WO1998048837A9 Polyalkylene oxide-modified single chain polypeptides |
| 04/22/1999 | WO1998047921A9 Mammalian cytokines; related reagents and methods |
| 04/22/1999 | WO1998045328A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 04/22/1999 | WO1998036779A3 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| 04/22/1999 | WO1998008934A9 Serum-free mammalian cell culture medium, and uses thereof |
| 04/22/1999 | CA2696653A1 Mammalian genes involved in viral infection and tumor suppression |
| 04/22/1999 | CA2315244A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/22/1999 | CA2308121A1 Mammals lacking expression of osteoprotegerin |
| 04/22/1999 | CA2308118A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 04/22/1999 | CA2308009A1 Novel npy family member |
| 04/22/1999 | CA2307328A1 Cell division regulators |
| 04/22/1999 | CA2306455A1 Human receptor proteins; related reagents and methods |
| 04/22/1999 | CA2306453A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 04/22/1999 | CA2306448A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 04/22/1999 | CA2306444A1 Inhibition of human immunodeficiency virus (hiv-1) replication |
| 04/22/1999 | CA2306443A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 04/22/1999 | CA2306440A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 04/22/1999 | CA2306207A1 Geranyl diphosphate synthase from mint (mentha piperita) |
| 04/22/1999 | CA2305748A1 Liver regeneration using pancreas cells |
| 04/22/1999 | CA2305698A1 Human progesterone receptor complex p23-like protein |
| 04/22/1999 | CA2305690A1 53 human secreted proteins |
| 04/22/1999 | CA2305643A1 Murine model for human carcinoma |
| 04/22/1999 | CA2303844A1 Regulators of ucp3 gene expression |
| 04/22/1999 | CA2275135A1 Phosphodiesterase 8a |
| 04/21/1999 | EP0909816A1 Anti-fas antibodies |
| 04/21/1999 | EP0909815A2 Dna sequence conferring cytoplasmic male sterility, mitochondrial genome, nuclear genome, mitochondria and plant containing said sequence and process for the preparation of hybrids |
| 04/21/1999 | EP0909814A2 Use of protein kinases for the diagnosis and treatment of Alzheimer's disease |
| 04/21/1999 | EP0909813A1 Totipotent hematopoietic stem cell receptors -flk-1 and flk-2, and their ligands |
| 04/21/1999 | EP0909321A2 Mammalian chemokine reagents |
| 04/21/1999 | EP0909319A2 Growth arrest gene compositions and methods |
| 04/21/1999 | EP0909318A1 Human stem cell antigens, dna coding therefor and their use |
| 04/21/1999 | EP0909317A1 Composition and methods for modulating the length of telomeres |
| 04/21/1999 | EP0909316A1 Glial cell line-derived neurotrophic factor receptor |
| 04/21/1999 | EP0909314A1 Plant sugar sensors and uses thereof |
| 04/21/1999 | EP0909313A1 Methods for creating transgenic animals |
| 04/21/1999 | EP0909278A1 Nephropathy-related immunoglobulin g and antibodies for same |
| 04/21/1999 | EP0909277A2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 04/21/1999 | EP0909181A1 Novel compounds |
| 04/21/1999 | EP0909180A1 Novel compounds |
| 04/21/1999 | EP0791205A4 Biological analysis system self-calibration apparatus |
| 04/21/1999 | EP0690671A4 Method and apparatus for encapsulation of biologically-active substances in cells |
| 04/21/1999 | EP0674660B1 Multifunctional neurotrophic factors |
| 04/21/1999 | EP0664834B1 Recombinant humanized anti-cytomegalovirus antibodies |
| 04/21/1999 | EP0644947B1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses |
| 04/21/1999 | EP0640131B1 Genetically engineered antibodies |
| 04/21/1999 | CN1214738A Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer methastasis formation |
| 04/21/1999 | CN1214736A Promoter from tobacco |
| 04/21/1999 | CN1214734A SCF analog compositions and method |
| 04/21/1999 | CN1214695A ErdB3 antibodies |
| 04/21/1999 | CN1214692A Tumor rejection antigens presented by HLA-B44 molecules and uses thereof |
| 04/21/1999 | CN1214195A Disease resistant plant including thionin gene |
| 04/20/1999 | US5895833 Gene expression compatible with mammary glands |
| 04/20/1999 | US5895813 Diagnosis and treatment of TKA-1 related disorders |
| 04/20/1999 | US5895757 Encapsulation of living tissue cells in inorganic microspheres prepared from an organosilicon |
| 04/20/1999 | US5895745 Method of thawing cryopreserved cells |
| 04/20/1999 | CA1340505C Bovine placental lactogen |
| 04/15/1999 | WO1999018226A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/15/1999 | WO1999018224A1 Plant fatty acid hydroxylase genes |
| 04/15/1999 | WO1999018222A1 Use of beta recombinase in eukaryotic cells, especially for transgenic work |
| 04/15/1999 | WO1999018221A1 Method for introducing and expressing rna in animal cells |
| 04/15/1999 | WO1999018219A1 A keratinocyte derived protease |
| 04/15/1999 | WO1999018217A1 Method for producing branched fatty acids using genetically modified plants |
| 04/15/1999 | WO1999018209A1 A HUMAN 2-19 PROTEIN HOMOLOGUE, z219a |
| 04/15/1999 | WO1999018208A1 101 human secreted proteins |
| 04/15/1999 | WO1999018199A2 cDNAs CODING FOR HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS |
| 04/15/1999 | WO1999018195A2 Methods and compositions for inducing tumor-specific cytotoxicity |
| 04/15/1999 | WO1999018193A1 Jnk3 modulators and methods of use |
| 04/15/1999 | WO1999018187A1 NOVEL clpL |
| 04/15/1999 | WO1999018128A1 Fibroblast growth factor with hepatocyte proliferation activity |
| 04/15/1999 | WO1999018127A1 Secreted proteins and polynucleotides encoding them |
| 04/15/1999 | WO1999018117A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus |
| 04/15/1999 | WO1999017800A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | WO1999017796A2 Modulation of lerk-2-mediated cell adhesion |
| 04/15/1999 | WO1999017795A1 RIBOSOME RECYCLING FACTOR (FRR) OF $i(STAPHYLOCOCCUS AUREUS) |
| 04/15/1999 | WO1999017794A1 UDP-N-ACETYLMURAMOYL-L-AIANINE:D-GLUTAMATE LIGASE (murD) OF STAPHYLOCOCCUS AUREUS |
| 04/15/1999 | WO1999017741A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | WO1999009054A3 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 04/15/1999 | WO1999007738A3 Human orphan receptor ntr-1 |
| 04/15/1999 | WO1999005502A3 Modulation of multicellular aggregates by solid stress |
| 04/15/1999 | WO1999005300A3 Ghrh expression system and methods of use |
| 04/15/1999 | WO1999005262A3 Method for obtaining an epithelial cell sheet |
| 04/15/1999 | WO1999005170A8 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 04/15/1999 | WO1999003872A9 Nucleic acid ladders |
| 04/15/1999 | WO1999002655A9 Protein kinases and uses thereof |
| 04/15/1999 | WO1999002171A9 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 04/15/1999 | WO1999000422A9 Novel family of pheromone receptors |
| 04/15/1999 | WO1998059061A9 Male tissue-preferred regulatory region and method of using same |
| 04/15/1999 | WO1998059058A3 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds |
| 04/15/1999 | WO1998058945A9 Compounds encoding the protective m-like protein of streptococcus equi and assays therefor |
| 04/15/1999 | WO1998052582A8 Non-myeloablative tolerogenic treatment |
| 04/15/1999 | WO1998048022A9 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 04/15/1999 | WO1998045322A3 Diagnosis method and reagents |
| 04/15/1999 | DE19821060A1 Ko-stimulierendes Polypeptid von T-Zellen, monoklonale Antikörper sowie die Herstellung und deren Verwendung Co-stimulatory polypeptide of T-cells, monoclonal antibodies and the production and use thereof |
| 04/15/1999 | CA2309791A1 Plant fatty acid hydroxylase genes |
| 04/15/1999 | CA2308126A1 Modulation of lerk-2-mediated cell adhesion |
| 04/15/1999 | CA2308123A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | CA2305848A1 Cdnas coding for human proteins having transmembrane domains |
| 04/15/1999 | CA2305815A1 Use of beta recombinase in eukaryotic cells, especially for transgenic work |
| 04/15/1999 | CA2305785A1 Method for introducing and expressing rna in animal cells |
| 04/15/1999 | CA2305782A1 Method for producing branched fatty acids using genetically modified plants |